Search clinical trials for: Aromatase Inhibitors (Aromasin)
Total 64416 results
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
PfizerTerminated
-
PfizerCompletedPost Menopausal Women With Early Breast Cancer
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Actavis Inc.Withdrawn
-
Masonic Cancer Center, University of MinnesotaCompleted
-
PfizerCompleted
-
PfizerCompletedBreast NeoplasmsChina
-
Roxane LaboratoriesCompleted
-
PfizerTerminated
-
Nordic Society of Gynaecological Oncology - Clinical...Completed
-
Roxane LaboratoriesCompletedBreast CancerUnited States
-
Roxane LaboratoriesCompleted
-
PfizerCompletedBreast NeoplasmsFrance
-
PfizerCompleted
-
National University Hospital, SingaporeUnknownBreast CarcinomaSingapore
-
Georgetown UniversityNovartis PharmaceuticalsTerminated
-
Dharmais National Cancer Center HospitalCompleted
-
PfizerTerminatedBreast NeoplasmsSerbia, Croatia, Estonia
-
PfizerCompletedBreast CancerKorea, Republic of
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
Hellenic Breast Surgeons SocietyTerminated
-
PfizerCompleted
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
Chipscreen Biosciences, Ltd.Completed
-
Finn, Olivera, PhDBreast Cancer Research Foundation; A Glimmer of Hope FoundationRecruitingDuctal Carcinoma in SituUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Ohio State University Comprehensive Cancer CenterPfizerCompletedBreast CancerUnited States
-
PfizerCompletedBreast NeoplasmsBelgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
-
Inge Marie SvaneWithdrawn
-
Dartmouth-Hitchcock Medical CenterActive, not recruiting
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationTerminated
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterDamon Runyon Cancer Research FoundationCompletedPain | Breast Cancer | ArthralgiaUnited States
-
Centre Leon BerardRecruitingLow Grade Endometrial Stromal SarcomaFrance
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Baylor Breast Care CenterPfizerTerminatedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstitutePfizerCompleted
-
Kyowa Kirin Co., Ltd.CompletedAdvanced or Recurrent Breast CancerJapan
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical HyperplasiaUnited States
-
Gilead SciencesCompletedSolid Tumors and LymphomasUnited States
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States